JILL FROST: Open Payments
NPI 1952649204 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 25 payments from 10 companies in 2025. Trend: 2023 $1,221 · 2024 $604 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $172 |
| Radius Health, Inc. | 5 | $112 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
| Philips North America LLC | 2 | $28 |
| Aimmune Therapeutics, Inc. | 2 | $27 |
| BioMarin Pharmaceutical Inc. | 1 | $25 |
| TOLMAR, INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: FASENRA, Tymlos, CRENESSITY, TEZSPIRE, DUPIXENT, ALYFTREK, Vest Therapy Und, ZENPEP.
Industry payments across OK — which companies pay providers there.
